Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 31, Number 9—September 2025
Research Letter
Linezolid and Meropenem for Nocardia otitidiscaviarum Actinomycetoma, India
Figure 1

Figure 1. Anterior right knee of patient treated with linezolid and meropenem for Nocardia otitidiscaviarum actinomycetoma, India. A) Multiple nodules with overlying sinuses over right knee. B) Near-complete resolution with subsidence of sinuses and nodules leaving behind scarring after 2 months of treatment with a 21-day cycle of linezolid and meropenem combined with trimethoprim/sulfamethoxazole.
Page created: July 01, 2025
Page updated: August 18, 2025
Page reviewed: August 18, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.